Yahoo Web Search

Search results

1. en.wikipedia.org › wiki › Juno_TherapeuticsJuno Therapeutics - Wikipedia

   en.wikipedia.org › wiki › Juno_Therapeutics

   • Cached

   Website. www .bms .com. Juno Therapeutics Inc was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.

   • Founded: 2013
   • Industry: Biotechnology

   • Headquarters: Seattle, WA
   • Parent: Bristol-Myers Squibb

2. www.geekwire.com › 2022 › junos-lasting-legacy-how-Juno's lasting legacy: How the cell therapy juggernaut ...

   www.geekwire.com › 2022 › junos-lasting-legacy-how-

   • Cached

   Feb 8, 2022 · When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune...

   • 
   • 
   • 
   • 

3. www.crunchbase.com › organization › juno-therapeuticsJuno Therapeutics - Crunchbase Company Profile & Funding

   www.crunchbase.com › organization › juno-therapeutics

   • Cached

   Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer. View contacts for Juno Therapeutics to access new leads and connect with decision-makers.

   • Location: Seattle, Washington

   • Founder: Hans Bishop

   • Where is Juno Therapeutics's headquarters?

     Juno Therapeutics is located in Seattle, Washington, United States.
   • Who invested in Juno Therapeutics?

     Juno Therapeutics has 4 investors including ARCH Venture Partners And Bezos Expeditions.
   • How much funding has Juno Therapeutics raised to date?

     Juno Therapeutics has raised $310M.
   • When was the last funding round for Juno Therapeutics?

     Juno Therapeutics closed its last funding round on Aug 5, 2014 from a Series B round.
   • Who are Juno Therapeutics's competitors?

     Alternatives and possible competitors to Juno Therapeutics may include Carisma Therapeutics, Gritstone bio, And Tmunity Therapeutics.

4. Videos

   • 

     5:26

     youtube.com

     Juno Therapeutics on how it plans to kill cancer

     Dec 4, 2013

     3.7K Views

   • 

     7:00

     bloomberg.com

     Juno Therapeutics Focused on New Drugs for Immunotherapy - 1/8/2018

     Jan 8, 2018

     0 Views

   • 

     2:43

     cnbc.com

     Outricking cancer cells through immunotherapy: JUNO CEO

     Jul 24, 2015

     0 Views

   View all

5. www.fda.gov › news-events › press-announcementsFDA Approves New Treatment For Adults With Relapsed Or ...

   www.fda.gov › news-events › press-announcements

   • Cached

   Feb 5, 2021 · February 05, 2021. Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell...

6. www.geekwire.com › 2022 › junoJuno co-founder launches ambitious new startup with Fred ...

   www.geekwire.com › 2022 › juno

   • Cached

   Jan 14, 2022 · Greenberg previously co-founded cell therapy company Juno Therapeutics, which was acquired by Celgene for more than $9 billion in 2018. Co-founder Jak Knowles serves as Affini-T CEO and...

7. seekingalpha.com › article › 3791366-juno-leader-inJuno: A Leader In The Next Major Therapeutic Industry

   seekingalpha.com › article › 3791366-juno-leader-in

   Jan 5, 2016 · 460 Follower s. Summary. Cancer immunotherapy has emerged as a new viable market for the biotech industry. Antibodies and now cellular therapies are actively being pursued for the treatment of...

8. seekingalpha.com › article › 4005689Why Juno Therapeutics Could Be The Future ... - Seeking Alpha

   seekingalpha.com › article › 4005689

   Sep 12, 2016 · We consider Juno Therapeutics as the future leader in CAR-T and TCR space due to its next generation technologies like 3rd and 4th generation CARs, armored CARs, TCRs and potential to combine...